Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory maintenance trial of BI 655064 in lupus nephritis responders
2017-003101-17Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of BI 655064 in lupus nephritis (LN), sponsored by Boehringer Ingelheim. Primary endpoint: Complete renal response without renal flares. Started Oct 2017; status: completed.
02
Drugs
BI 655064
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on 2017-003101-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003101-17.